Cytogenetics is the branch of genetics that focuses on the structure and function of the cell and its chromosomes. Chromosomes are the hereditary material composed of DNA and proteins inside the nucleus of a cell. By studying the genetic makeup of a cell, we can understand how different organisms and their cells are coordinated and regulated. The primary tool of cytogenetics is the microscope, which allows researchers to visualize the chromosomes inside a cell at high resolution. These microscopic images help researchers understand various genetic events, from meiosis and mitosis to gene expression and transcription. In addition, microscopy can reveal the genetic level of abnormalities that may be present in the patient’s cells. Other analytical technologies used in cytogenetics include cytogenetic culture, which involves the study of dividing cell nuclei to infer the chromosome content and structure of the cells. Additionally, DNA sequencing technologies can be used to look at the base pairs of DNA in the chromosomes of an organism. By analyzing the genetic diseases associated with an organism, scientists can develop new treatments and therapies for those diseases. Finally, new technologies such as fluorescent in situ hybridization (FISH) and karyotyping allow researchers to gain a more detailed genetic analysis of an organism’s DNA. These techniques use dyes or probes to reveal specific locations of DNA segments inside the chromosomes. Such techniques are used to diagnose genetic disorders and chromosomal abnormalities. Cytogenetics is an important area of genetics that plays a huge role in understanding the genetic basis of diseases, and developing treatments to improve patient care. By focusing on the structure and function of cells and chromosomes, scientists can continue to make advances in genetic research.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom